ES2137136B1 - Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica. - Google Patents

Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Info

Publication number
ES2137136B1
ES2137136B1 ES009801021A ES9801021A ES2137136B1 ES 2137136 B1 ES2137136 B1 ES 2137136B1 ES 009801021 A ES009801021 A ES 009801021A ES 9801021 A ES9801021 A ES 9801021A ES 2137136 B1 ES2137136 B1 ES 2137136B1
Authority
ES
Spain
Prior art keywords
aryl
treatment
neurogenic inflammation
inflammation
heteroaril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009801021A
Other languages
English (en)
Other versions
ES2137136A1 (es
Inventor
Ramon Merce-Vidal
Jordi Frigola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to ES009801021A priority Critical patent/ES2137136B1/es
Priority to NZ508316A priority patent/NZ508316A/en
Priority to ARP990102325A priority patent/AR019555A1/es
Priority to EP99919290A priority patent/EP1086682B1/en
Priority to CA002332711A priority patent/CA2332711A1/en
Priority to CZ20004282A priority patent/CZ291593B6/cs
Priority to DK99919290T priority patent/DK1086682T3/da
Priority to ES99919290T priority patent/ES2196800T3/es
Priority to CNB998077216A priority patent/CN1221257C/zh
Priority to PT99919290T priority patent/PT1086682E/pt
Priority to AU37118/99A priority patent/AU759229B2/en
Priority to PL99344742A priority patent/PL344742A1/xx
Priority to RU2000131615/14A priority patent/RU2212237C2/ru
Priority to DE69906969T priority patent/DE69906969T2/de
Priority to AT99919290T priority patent/ATE237328T1/de
Priority to HU0102112A priority patent/HUP0102112A3/hu
Priority to IL13974498A priority patent/IL139744A0/xx
Priority to PCT/ES1999/000142 priority patent/WO1999059524A2/es
Priority to JP2000549190A priority patent/JP2002515409A/ja
Priority to KR1020007012955A priority patent/KR100572416B1/ko
Priority to TR2000/03434T priority patent/TR200003434T2/xx
Priority to BR9910587-0A priority patent/BR9910587A/pt
Priority to TW088108432A priority patent/TW570796B/zh
Publication of ES2137136A1 publication Critical patent/ES2137136A1/es
Application granted granted Critical
Publication of ES2137136B1 publication Critical patent/ES2137136B1/es
Priority to IL139744A priority patent/IL139744A/en
Priority to ZA200006732A priority patent/ZA200006732B/xx
Priority to NO20005837A priority patent/NO20005837L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboración de un medicamento para el tratamiento de la inflamación neurogénica.Los derivados de aril (o heteroaril) azolilcarbinol (I), donde R1 es un átomo de hidrógeno o un grupo alquilo inferior; R2 es un radical dialquilaminoelquilo o azaheterociclilalquilo; Ar es un radical fenilo o tienilo, opcionalmente sustituidos; y Het es un heterociclo aromático nitrogenado de 5 miembros que contiene de uno a tres átomos de nitrógeno, opcionalmente sustituido; son adecuados para el tratamiento de la inflamación neurogénica, presente en diferentes procesos, tales como diabetes, asma, cistitis, gingivitis, migraña, dermatitis, rinitis, psoriasis, inflamación de nervios ciáticoy lumbares, procesos gastrointestinales, inflamación ocular, etc., en mamíferos, incluido el hombre.
ES009801021A 1998-05-18 1998-05-18 Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica. Expired - Fee Related ES2137136B1 (es)

Priority Applications (26)

Application Number Priority Date Filing Date Title
ES009801021A ES2137136B1 (es) 1998-05-18 1998-05-18 Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
NZ508316A NZ508316A (en) 1998-05-18 1999-01-13 A treatment for neurogenic inflammation in a variety of pathological conditions involving the activation of non-myelinated nerve fibres
ARP990102325A AR019555A1 (es) 1998-05-18 1999-05-14 Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica
IL13974498A IL139744A0 (en) 1998-05-18 1999-05-18 Use of derivates of aryl (or heteroaryl) azolycarbinols in the manufacture of a medicament for the treatment of neurogenic inflamation
CZ20004282A CZ291593B6 (cs) 1998-05-18 1999-05-18 Léčivo pro léčbu neurogenních zánětů
DK99919290T DK1086682T3 (da) 1998-05-18 1999-05-18 Anvendelse af aryl(eller heteroaryl)azolylcarbinolderivater ved fremstilling af et lægemiddel til behandling af neurogen betændelse
ES99919290T ES2196800T3 (es) 1998-05-18 1999-05-18 Usos de derivados de aril (oheteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion nueurogenica.
CNB998077216A CN1221257C (zh) 1998-05-18 1999-05-18 芳基(或杂芳基)唑基甲醇衍生物在制备用于治疗神经原性炎症的药物中的应用
PT99919290T PT1086682E (pt) 1998-05-18 1999-05-18 Utilizacao de derivados de arilo(ou heteroaril)azolil-carbinol na preparacao de um medicamento para o tratamento de inflamacao neurogenica
AU37118/99A AU759229B2 (en) 1998-05-18 1999-05-18 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
PL99344742A PL344742A1 (en) 1998-05-18 1999-05-18 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
RU2000131615/14A RU2212237C2 (ru) 1998-05-18 1999-05-18 Средство для лечения нейрогенного воспаления
DE69906969T DE69906969T2 (de) 1998-05-18 1999-05-18 Verwendung von aryl(oder heteroaryl)-azolylcarbinolderivaten in der herstellung von medikamenten zur behandlung von neurogenen entzündungen
AT99919290T ATE237328T1 (de) 1998-05-18 1999-05-18 Verwendung von aryl(oder heteroaryl)- azolylcarbinolderivaten in der herstellung von medikamenten zur behandlung von neurogenen entzündungen
EP99919290A EP1086682B1 (en) 1998-05-18 1999-05-18 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
CA002332711A CA2332711A1 (en) 1998-05-18 1999-05-18 Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of neurogenic inflammation
PCT/ES1999/000142 WO1999059524A2 (es) 1998-05-18 1999-05-18 Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica
JP2000549190A JP2002515409A (ja) 1998-05-18 1999-05-18 神経性炎症の治療のための薬の製造におけるアリール（又はヘテロアリール）アゾリルカルビノール誘導体の使用
KR1020007012955A KR100572416B1 (ko) 1998-05-18 1999-05-18 신경원성 질환의 치료를 위한 약물의 제조에 사용되는아릴(또는 헤테로아릴) 아졸일카르비놀 유도체
TR2000/03434T TR200003434T2 (tr) 1998-05-18 1999-05-18 Nörojenik iltihabın tedavisi için bir ilacın hazırlanması.
BR9910587-0A BR9910587A (pt) 1998-05-18 1999-05-18 Uso de derivados de aril(ou heteroaril) azolilcarbinóis na fabricacão de um medicamento para tratamento de inflamação neurogênica
HU0102112A HUP0102112A3 (en) 1998-05-18 1999-05-18 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
TW088108432A TW570796B (en) 1998-05-18 1999-05-24 Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of neurogenic inflammation
IL139744A IL139744A (en) 1998-05-18 2000-11-17 Use of derivatives of aryl or troaryl azolylcarbinols in the manufacture of a drug for the treatment of neurogenic inflammation
ZA200006732A ZA200006732B (en) 1998-05-18 2000-11-17 Utilization of Aryl (or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation.
NO20005837A NO20005837L (no) 1998-05-18 2000-11-17 Anvendelse av aryl (eller heteroaryl) azolylkarbinolderivater ved fremstilling av et medikament for behandling av neurogen inflammasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801021A ES2137136B1 (es) 1998-05-18 1998-05-18 Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Publications (2)

Publication Number Publication Date
ES2137136A1 ES2137136A1 (es) 1999-12-01
ES2137136B1 true ES2137136B1 (es) 2000-07-01

Family

ID=8303801

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009801021A Expired - Fee Related ES2137136B1 (es) 1998-05-18 1998-05-18 Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES99919290T Expired - Lifetime ES2196800T3 (es) 1998-05-18 1999-05-18 Usos de derivados de aril (oheteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion nueurogenica.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99919290T Expired - Lifetime ES2196800T3 (es) 1998-05-18 1999-05-18 Usos de derivados de aril (oheteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion nueurogenica.

Country Status (24)

Country Link
EP (1) EP1086682B1 (es)
JP (1) JP2002515409A (es)
KR (1) KR100572416B1 (es)
CN (1) CN1221257C (es)
AR (1) AR019555A1 (es)
AT (1) ATE237328T1 (es)
AU (1) AU759229B2 (es)
BR (1) BR9910587A (es)
CA (1) CA2332711A1 (es)
CZ (1) CZ291593B6 (es)
DE (1) DE69906969T2 (es)
DK (1) DK1086682T3 (es)
ES (2) ES2137136B1 (es)
HU (1) HUP0102112A3 (es)
IL (2) IL139744A0 (es)
NO (1) NO20005837L (es)
NZ (1) NZ508316A (es)
PL (1) PL344742A1 (es)
PT (1) PT1086682E (es)
RU (1) RU2212237C2 (es)
TR (1) TR200003434T2 (es)
TW (1) TW570796B (es)
WO (1) WO1999059524A2 (es)
ZA (1) ZA200006732B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2174756B2 (es) * 2001-04-06 2003-11-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
CA2495498C (en) * 2002-08-12 2014-04-15 Birkir Sveinsson Use of cgrp antagonist compounds for treatment of psoriasis
EP1784178A1 (en) * 2004-07-30 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1820502A1 (en) * 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
FR2681322B1 (fr) * 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.

Also Published As

Publication number Publication date
AR019555A1 (es) 2002-02-27
PL344742A1 (en) 2001-11-19
WO1999059524A3 (es) 2000-03-09
AU3711899A (en) 1999-12-06
DE69906969T2 (de) 2003-12-11
CN1306424A (zh) 2001-08-01
KR100572416B1 (ko) 2006-04-18
CN1221257C (zh) 2005-10-05
AU759229B2 (en) 2003-04-10
IL139744A0 (en) 2002-03-10
IL139744A (en) 2007-08-19
CZ291593B6 (cs) 2003-04-16
EP1086682A2 (en) 2001-03-28
ATE237328T1 (de) 2003-05-15
HUP0102112A2 (hu) 2002-03-28
ZA200006732B (en) 2002-08-16
NZ508316A (en) 2002-02-01
BR9910587A (pt) 2001-01-30
KR20010034868A (ko) 2001-04-25
DK1086682T3 (da) 2003-06-23
CZ20004282A3 (en) 2001-05-16
DE69906969D1 (de) 2003-05-22
EP1086682B1 (en) 2003-04-16
TR200003434T2 (tr) 2001-04-20
ES2196800T3 (es) 2003-12-16
HUP0102112A3 (en) 2002-06-28
NO20005837D0 (no) 2000-11-17
WO1999059524A2 (es) 1999-11-25
TW570796B (en) 2004-01-11
NO20005837L (no) 2001-01-08
RU2212237C2 (ru) 2003-09-20
PT1086682E (pt) 2003-07-31
JP2002515409A (ja) 2002-05-28
ES2137136A1 (es) 1999-12-01
CA2332711A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
ES2150378B1 (es) Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
Tripathi et al. Design and development of novel N-(pyrimidin-2-yl)-1, 3, 4-oxadiazole hybrids to treat cognitive dysfunctions
BR0109161A (pt) Beta-carbolinas substituìdas com atividade de inibição de ikb-quinase
BR0214023A (pt) Derivados de 1,2,4-tiadiazólio como moduladores de receptor de melanocortina
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
AR015105A1 (es) Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende
ECSP055633A (es) Nuevos derivados de benzoimidazolutiles como angentes antiproliferativos
ECSP034762A (es) Nuevos compuestos antiinflamatorias de triazolopiridinas
ES2137136B1 (es) Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
DE69426331T2 (de) Arzneimittel gegen nervöse erkrankungen
MXPA05014107A (es) Compuestos, formulaciones y metodos para tratar o prevenir el acne rosacea.
BR0012984A (pt) Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica
NO20065456L (no) Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet
BR0214096A (pt) Inibidores da pde9 para o tratamento de distúrbios cardiovasculares
ES2150353A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
AR007626A1 (es) N-[4-(heteroaril-metil)fenil]-heteroarilaminas, composicion que las contiene, proceso para preparar dicha composicion y proceso para preparar dichos compuestos
DK1178982T3 (da) Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
WO2012062905A3 (en) Chromene derivatives and their analoga as wnt pathway antagonists
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
NO984761L (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
TW200508221A (en) New azetidine compounds
AU5172585A (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
MX9205374A (es) Piridinil-amino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo(b)tiofenos y 1,2-benzo-isotiazoles sustituidos, un procedimiento para su preparacion y su utilizacion como medicamentos.
UA112109C2 (uk) Сульфонамідні похідні бензиламіну для лікування захворювань центральної нервової системи (цнс)

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19991201

Kind code of ref document: A1

Effective date: 19991201

FD2A Announcement of lapse in spain

Effective date: 20170216